Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

South Korea's MDFS clears initiation of phase I study of lenzilumab for COVID-19

July 23, 2021

Dosing starts in phase Ib study of Zotatifin in COVID-19

July 23, 2021

Addition of CF-296 to SOC leads to enhanced antibacterial activity against MSSA and MRSA isolates

July 22, 2021

Apoptosis inhibitors show promise in severe TB models

July 22, 2021

Sorrento initiates dosing in U.K. phase II study of COVI-DROPS in outpatient setting

July 22, 2021

FDA approves IND for phase I/II study of Zofin in COVID-19 long haulers

July 22, 2021

FDA clears IND for phase I/II trial of ExoFlo to treat post-acute COVID-19 syndrome

July 21, 2021

Tecnimede-Sociedade Tecnico-Medicinal discloses compounds for tuberculosis

July 21, 2021

Bacteriophage endolysin LysECD7 shows promising antibiofilm activity

July 21, 2021

Grant supports clinical development of ISA-104 for chronic hepatitis B

July 20, 2021

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...